Biomarkers in diverticular diseases of the colon

Digestive Diseases

Volumn 30, Issue 1, 2012, Pages 12-18

  Tursi, Antonio ^a,b  

^a ASL BAT   (Italy)

^b NONE   (Italy)

Author keywords

Biomarkers; C reactive protein; Erythrocyte sedimentation rate; Fecal calprotectin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN; CASPASE 9; GALANIN; GAMMA INTERFERON; GELATINASE A; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; NEUROPEPTIDE K; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SUBSTANCE P; TACHYKININ; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; COLON DIVERTICULOSIS; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LEUKOCYTE COUNT; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE;

EID: 84861071938     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000335695     Document Type: Article

References (40)

1. Jun S, Stollman N: Epidemiology of diverticular disease. Best Pract Res Clin Gastroenterol 2002; 16: 529-542.
2. Tursi A, Papagrigoriadis S: Review article: the current and evolving treatment of colonic diverticular disease. Aliment Pharmacol Ther 2009; 30: 532-546.
3. Narayan R, Floch MH: Microscopic colitis as part of the natural history of diverticular disease (abstract). Am J Gastroenterol 2002; 97(suppl):112.
4. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Danese S, Aiello F: Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol 2008; 42: 699-703.
5. Cianci R, Iacopini F, Petruzziello L, Cammarota G, Pandolfi F, Costamagna G: Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol 2009; 44: 108-115.
6. Pereira JM, Sirlin CB, Pinto PS, Jeffrey RB, Stella DL, Casola G: Disproportionate fat stranding: a helpful CT sign in patients with acute abdominal pain. Radiographics 2004; 24: 703-715. (Pubitemid 38703237)
7. Tursi A, Brandimarte G, Giorgetti G, Elisei W, Maiorano M, Aiello F: The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Dig Dis Sci 2008; 53: 2474-2479.
8. Tursi A, Elisei W, Giorgetti GM, Aiello F, Brandimarte G: Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Aliment Pharmacol Ther 2011; 33: 358-365.
9. Baumann BM, Chen EH, Mills AM, Glaspey L, Thompson NM, Jones MK, Farner MC: Patient perceptions of computed tomographic imaging and their understanding of radiation risk and exposure. Ann Emerg Med 2011; 58: 1-7.
10. Winter DC: Commentary: Perspectives on diverticulitis and the art of clinical science - treat the man not the scan. Colorectal Dis 2010; 12: 186-187.
11. Hale WB, NDSG: Colonoscopy in the diagnosis and management of diverticular disease. J Clin Gastroenterol 2008; 42: 1142-1144.
12. Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.
13. Desai D, Faubion WA, Sandborn WJ: Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 2007; 25: 247-255. (Pubitemid 46115394)
14. Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ: Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 707-712. (Pubitemid 41271173)
15. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I: Use of surrogate markers of inflammation and Rome criteria to distinguish organic from non-organic intestinal disease. Gastroenterology 2002; 123: 450-460. (Pubitemid 34827189)
16. Köhler L, Sauerland S, Neugebauer E, Scientific Committee of the European Association for Endoscopic Surgery (EAES): Diagnosis and treatment of diverticular disease. Results of a Consensus Development Conference. Surg Endosc 1999; 13: 430-436. (Pubitemid 29185515)
17. Laméris W, van Randen A, van Gulik TM, Busch OR, Winkelhagen J, Bossuyt PM, Stoker J, Boermeester MA: A clinical decision rule to establish the diagnosis of acute diverticulitis at the emergency department. Dis Colon Rectum 2010; 53: 896-904.
18. Andeweg CS, Knobben L, Hendriks JC, Bleichrodt RP, van Goor H: How to diagnose acute left-sided colonic diverticulitis: proposal for a clinical scoring system. Ann Surg 2011; 253: 940-946.
19. Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Aiello F: Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis. J Clin Gastroenterol 2010; 44: 702-706.
20. Käser SA, Fankhauser G, Glauser PM, Toia D, Maurer CA: Diagnostic value of inflammation markers in predicting perforation in acute sigmoid diverticulitis. World J Surg 2010; 34: 2717-2722.
21. Ridgway PF, Latif A, Shabbir J, Ofriokuma F, Hurley MJ, Evoy D, O'Mahony JB, Mealy K: Randomized controlled trial of oral vs. intravenous therapy for the clinically diagnosed acute uncomplicated diverticulitis. Colorectal Dis 2009; 11: 941-946.
22. Hall JF, Roberts PL, Ricciardi R, Read T, Scheirey C, Wald C, Marcello PW, Schoetz DJ: Long-term follow-up after an initial episode of diverticulitis: what are the predictors of recurrence? Dis Colon Rectum 2011; 54: 283-288.
23. Etzioni DA, Chiu VY, Cannom RR, Burchette RJ, Haigh PI, Abbas MA: Outpatient treatment of acute diverticulitis: rates and predictors of failure. Dis Colon Rectum 2010; 53: 861-865.
24. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Sterpi C, Marchi S, Maltinti G: Role of faecal calprotectin as a non-invasive marker of intestinal inflammation. Dig Liver Dis 2003; 35: 642-647. (Pubitemid 41110875)
25. Tibble J, Teahon K, Thjodleifssan B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I: A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506-513.
26. Pezzilli R, Barrassi A, Morselli Labate AM, Tinozzi S, Fantini I, Gizzi G, Latzniker M, Villani V, Melzi D'Eril G, Corinaldesi R: Fecal calprotectin levels in patients with colonic polyposis. Dig Dis Sci 2008; 53: 47-51. (Pubitemid 350265648)
27. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F: Faecal calprotectin in colonic diverticular disease: a casecontrol study. Int J Colorectal Dis 2009; 24: 49-55.
28. Vestergaard TA, Nielsen SL, Dahlerup JF, Hornung N: Fecal calprotectin: assessment of a rapid test. Scand J Clin Lab Invest 2007;i:1-5.
29. Dumitru E, Alexandrescu L, Suceveanu AI, Dumitru IM, Tofolean IT: Fecal calprotectin in diagnosis of complicated colonic diverticular disease. Gastroenterology 2010; 138(suppl 1):S365.
30. Turkay C, Kasapoglu B: Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics (Sao Paulo) 2010; 65: 221-231.
31. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, Bjarnason I: High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999; 45: 362-366. (Pubitemid 29400711)
32. Johne B, Kronborg O, Tøn HI, Kristinsson J, Fuglerud P: A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol 2001; 36: 291-296. (Pubitemid 32234579)
33. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, De- Carlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250. (Pubitemid 23103292)
34. Mimura T, Bateman AC, Lee RL, Johnson PA, McDonald PJ, Talbot IC, Kamm MA, MacDonald TT, Pender SL: Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease. Dis Colon Rectum 2004; 47: 371-378.
35. Klinge U, Rosch R, Junge K, Krones CJ, Stumpf M, Lynen-Jansen P, Mertens PR, Schumpelick V: Different matrix micro-environments in colon cancer and diverticular disease. Int J Colorectal Dis 2007; 22: 515-520. (Pubitemid 46488056)
36. Rosemar A, Ivarsson ML, Börjesson L, Holmdahl L: Increased concentration of tissue- degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Scand J Gastroenterol 2007; 42: 215-220.
37. Mäkitalo L, Sipponen T, Kärkkäinen P, Kolho KL, Saarialho-Kere U: Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values. Int J Colorectal Dis 2009; 24: 1157-1167.
38. Gschossmann JM, Liebregts T, Adam B, Buenger L, Ruwe M, Gerken G, Holtmann G: Long-term effects of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension. Dig Dis Sci 2004; 49: 96-101. (Pubitemid 38183752)
39. Simpson J, Sundler F, Humes DJ, Jenkins D, Scholefield JH, Spiller RC: Post-inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil 2009; 21:e847-e858.
40. Elli L, Roncoroni L, Bardella MT, Terrani C, Bonura A, Ciulla M, Marconi S, Piodi L: Absence of mucosal inflammation in uncomplicated diverticular disease. Dig Dis Sci 2011; 56: 2098-2103.